Navigation Links
Genetic Pattern May Predict Leukemia Relapse
Date:5/13/2010

Children could be screened, treated more aggressively if deemed at risk, researchers say

THURSDAY, May 13 (HealthDay News) -- Researchers have linked a genetic pattern to the likelihood that patients with a severe form of childhood leukemia will relapse.

The finding could lead doctors to screen for the pattern and treat those who have it more aggressively from the time of diagnosis, the researchers added.

The kids in question have T-cell acute lymphoblastic leukemia, which accounts for about 15 percent of childhood leukemia cases.

While as many as 80 percent of children with the disease go into remission, about 20 percent relapse, study co-author Alex Beesley, of Perth's Telethon Institute for Child Health Research in Australia, said in a news release.

The prognosis for those patients can be grim, he said.

"In this study, we found a consistent pattern in the expression of five genes in patients that relapse," Beesley said. "Importantly, this pattern was found to hold true across multiple patient cohorts, the first time that such a robust gene signature of this kind has been found" for the type of leukemia in question.

"Patients identified using these markers could potentially be treated with more aggressive therapies from the outset to give them the best hope of achieving complete remission," Beesley said.

The study authors came to their conclusions after analyzing bone-marrow samples from children with leukemia. They found a genetic pattern that successfully predicted what would happen to 50 patients with the form of leukemia.

The findings were published online May 12 in the journal Molecular Cancer.

More information

For more about leukemia in kids, see the U.S. National Library of Medicine.



-- Randy Dotinga



SOURCE: BioMed Central, news release, May 11, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Walgreens Postpones Plans to Sell Do-It-Yourself Genetic Test
2. Genetic pattern that predicts leukemia relapse discovered
3. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
4. Genetic Variants Tied to MS, Study Finds
5. UT Southwestern participates in nationwide study offering free lung tumor genetic testing
6. Genetic Research Sheds Light on Chronic Pain
7. High doses of antioxidant supplements induce stem cell genetic abnormalities
8. New research about human genetic diseases and human development
9. Genetics, Psychology May Trigger ADHD
10. Plant pathogen genetically tailors attacks to each part of host, say Stanford researchers
11. Study finds changes in fetal epigenetics throughout pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Alert Sentry Group LLC., a leader in the Personal Emergency ... iSAFE and the iSAFE Plus. These iSAFE products are the most affordable and most ... and iSAFE Plus offer direct GPS Location and two-way calling with the push of ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. ... will speak to the press on behalf of over 200 doctors, scientists, and scientific ... commission. , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, ...
(Date:3/28/2017)... VA (PRWEB) , ... March 28, 2017 , ... The ... Still, MHA, FRBMA, has begun to serve as its new executive director. Mr. Still ... the Executive Search Committee. , “Bob, as he is known to our members, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning ... will begin serving as new board chair for Orange County health care system ... the remainder of soon-to-be former chair Mark Refowitz’s term, which runs through June ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of two biometric time and attendance tracking products: the new NCheck Cloud Bio ... Cloud Bio Attendance uses biometric face recognition to enable users to check in ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... SAN MATEO, Calif. , March 27, 2017 ... has been acquired by Ethicon, a division of ... Reflux Management System for the treatment of gastro-esophageal ... on magnetic sphincter augmentation (MSA) technology and the ... European medical centers. Torax Medical was ...
(Date:3/27/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... AGI-134, an immunotherapy for the treatment of multiple cancers, obtained ... featured at the upcoming American Association for Cancer Research ... to be held on April 1-5, 2017. ... An abstract titled ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
Breaking Medicine Technology: